NASDAQ:ZYME - Nasdaq - US98985Y1082 - Common Stock - Currency: USD
TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 93.27M | 76.30M | 76.01M | 412.50M | 26.70M | |||
Operating Expenses | 201.00M | 196.00M | 214.00M | 282.00M | 242.30M | |||
Research and Development | N/A | 134.62M | 143.72M | 208.60M | N/A | |||
Selling, General, and Administrative Expenses | 63.00M | 62.00M | 70.00M | 73.40M | 42.60M | |||
Operating Income | -108.00M | -120.00M | -138.00M | 130.50M | -215.60M | |||
Interest Income/Expense | N/A | 20.72M | 18.52M | 4.70M | 3.20M | |||
Other Income/Expense | 3.76M | -220.00K | 290.00K | 0.00 | 100.00K | |||
Non Recurring Items | N/A | -17.00M | N/A | N/A | 0.00 | |||
Income Before Taxes | -108.00M | -117.00M | -119.00M | 135.20M | -212.40M | |||
Income Tax | 6.52M | 6.08M | -570.00K | 10.90M | -500.00K | |||
Net Income | -115.00M | -123.00M | -119.00M | 124.30M | -211.80M | |||
EBITDA | -100.10M | -111.31M | -127.84M | 137.70M | -209.10M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.49 | -1.62 | -1.72 | 1.91 | -4.11 | |||
Non GAAP EPS | -1.27 | -1.39 | -1.73 | 1.93 | -4.11 | |||
Statistics | ||||||||
Profit Margin | -123.29% | -161.20% | -156.55% | 30.13% | -793.26% | |||
Operating Profit Margin | -115.79% | -157.27% | -181.55% | 31.64% | -807.49% |
All data in USD